I’m genuinely not aware of a DIY or grey market in vaccines. Peptides, yes, but vaccines?
In the absence of this, I suspect you’re either confused or straw-manning…
To clarify, is your concern the inadequacy of the approval process FDA uses for (all) vaccines (noting that many vaccines --e.g. influenza-- are refreshed on a fairly regular basis to account for new strains of viruses) or something specific to approval of the MRNA vaccines?
Or is it that MRNA vaccines were a new approach for vaccines more generally, and so there wasn't/isn't the same long-term data that there was/is for multiple generations of vaccines based on older technologies (viral vector, toxoid, etc.)?
I disagree; "untested" is a very definitive statement. Not tested. Especially when it's in a thread discussing people using all manner of less tested or sometimes literally untested peptides. (Hence my initial thought that maybe you were aware of people taking a DIY route that I wasn't.)
Anyway, when discussing a subject so popularly controversial as vaccines, it's probably better to be precise.
> And the second, but what’s your point?
I wanted to understand your perspective.